Mar 1, 2023 | International Laboratory News, Laboratory Pathology, Laboratory Testing, Molecular Diagnostics, Genetic Testing, Whole Gene Sequencing
Another study in the United Kingdom that also used genomic analysis to understand drug-resistant Shigella produced findings that may be useful for microbiologists and medical laboratory scientists From the onset of an infectious disease outbreak, public health officials, microbiologists, and clinical laboratory managers find it valuable to trace the origin of the spread back to the “index case” or “patient zero”—the first documented patient in the disease epidemic. Given the decreased cost of...
Feb 11, 2015 | Coding, Billing, and Collections, Compliance, Legal, and Malpractice, Digital Pathology, Instruments & Equipment, Laboratory Instruments & Laboratory Equipment, Laboratory Pathology
This collaborative effort with microbiology labs will keep microbiologists at the forefront of infectious disease diagnostics A partnership of San Diego-based genome sequencing company Illumina, and the French multinational, in vitro diagnostics company bioMérieux, plans to launch a next-generation sequencing (NGS) epidemiology service that will allow microbiologists to rapidly identify strains that threaten hospital inpatients and public health, according to a press release distributed by the...
Dec 18, 2009 | Laboratory News, Laboratory Pathology
Researchers say Mobidiag’s microarray-based diagnostic test technology looks promising There’s a new DNA-based microarray platform that could speed identification of blood-borne pathogens. By allowing clinical laboratories to deliver test results in just 18 hours, use of this new microarray could improve early detection and management of sepsis patients. In a study headed by Päivi Tissari, M.D., of the Division of Clinical Microbiology, Helsinki University Hospital Laboratory in Finland, the...
Dec 7, 2009 | Laboratory Management and Operations, Laboratory News, Laboratory Pathology
Canadian scientist steals specimens, caught by U.S. Customs agent at the border Laboratories are invariably out of the public eye—until there is a problem. In Canada, The Canadian Press reported earlier this year that audits had uncovered serious flaws in the tracking and accountability of dangerous pathogen specimens at federal laboratories. In response, the Public Health Agency of Canada (PHAC) called for increased security measures governing bio-safety at government laboratories. These...